Research article · 3 May 2019
Conference abstract
QSAR by hansch analysis
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The identification of a new drug molecule using the traditional medicinal chemistry approach requires lot of synthesis, time and money. It was identified that out of billions molecules synthesized, around one or two molecules reach the clinical trials. This produces hurdle in the discovery new chemical entities (NCEs) for the treatment of various diseases by traditional drug discovery process. The aforementioned facts necessitated researchers to search for the alternate methods which determine the biological activity of the molecules without synthesizing them. Since the 1960s, enormous efforts have been made by various investigators to develop quantitative parameters to describe the biological activity. During this period, Hansch and co-workers made important breakthroughs for biological QSAR with electronic, stereo and hydrophobic parameters to be known as the Hansch analysis. The Hansch analysis involves the development of a mathematical model which correlates the physicochemical parameters of molecules (lipophilic, electronic, steric and toplogical properties etc.) with their biological activity. The developed Hansch model can be used to predict the activity of NCEs without the need to synthesize them. The various facts to be considered before the development of Hansch analysis are: Rule of thumb, Selection of training and test set, Cross validated r2 (r2cv or q2), Outlier detection and their removal, Multicollinearity (autocorrelation) observed between the parameters and Detection of systemic errors. The various steps involved in the development of Hansch analysis include Sketch and energy minimize the molecules under test, Calculate the molecular descriptors, Convert the biological units into logarithmic units, Derive QSAR equation using training set by linear or multiple linear regression (MLR) and Cross validate the QSAR model by calculation of q2 and ability of developed QSAR model to predict the biological activity of test set which is excluded from the model development.
Subjects
Nursing & HealthcareAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Perspective · 30 Jun 2023
Applications in Discovering New Drugs using Quantitative Structure-Activity Relationship Analysis (QSAR) Model
Opinion · 30 Nov 2022
Study of Quantitative Structure-Activity Relationship Analysis (QSAR) for Drug Development
Research article · 3 Mar 2022
In Silico Molecular Modeling Study on Isatin Derivatives as Anti-Covid Agents Based on Qsar and Docking Analysis
Research article · 16 Jun 2020
andldquo;3D-QSAR Analysis and Molecular Docking Studies on 3-Arylcoumarin Derivatives as Potential andalpha;- Glucosidase Inhibitors.andrdquo
More from this journal
The newest in Health Care : Current Reviews.
Article · 20 Aug 2025
Factors Associated with Mortality in the Pediatric Intensive Care Unit at Bernard Mevs Hospital in Haiti
Article · 15 Aug 2025
Pharmacogenomics and the Future of Drug Development: A Current Review
Article · 15 Aug 2025
Artificial Intelligence in Health Care: Current Applications and Future Directions
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalHealth Care : Current Reviews
- SubjectNursing & Healthcare
- BylineArticles whose byline prints “Narasimhan B”

